Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(7)
DRUG(6)
BIOLOGICAL(1)
PROCEDURE(1)
Cytarabine
2 trials
phase_1phase_1_2
washington-university-school-of-medicine
Ifosfamide
1 trial
early_phase_1
washington-university-school-of-medicine
Dexamethasone
1 trial
early_phase_1
washington-university-school-of-medicine
Etoposide
1 trial
phase_1
washington-university-school-of-medicine
Plerixafor
1 trial
phase_1
washington-university-school-of-medicine
Mitoxantrone
1 trial
phase_1
washington-university-school-of-medicine
Cladribine
1 trial
phase_1_2
washington-university-school-of-medicine
Leukapheresis
1 trial
phase_2
washington-university-school-of-medicine

+6 more interventions

14 unique interventions4 categories

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed3
Terminated1
Other1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT05377827Phase 1Suspended
Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Acute Myeloid LeukemiaAdult T Cell LeukemiaAdult T Cell Lymphoma+12 more
PrincipalinvestigatorStart date: 2023-10-10
NCT02639559Phase 2Completed
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+7 more
PrincipalinvestigatorStart date: 2016-03-31
NCT02416908Phase 1/2Completed
Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia
Acute Myeloid Leukemia
PrincipalinvestigatorStart date: 2015-06-16
NCT01027923Phase 1Terminated
IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)
Leukemia, Myeloid, Acute
Principalinvestigator
NCT01331590Early Phase 1Completed
Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, Acute+4 more
Similarity Score10%

Yves Beguin, MD, PhD

CHU-ULg

Related
7 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+4 more
Similarity Score10%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseMultiple MyelomaLymphoma, Non-Hodgkin+3 more
Similarity Score8%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+2 more
Similarity Score7%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic Syndromes+1 more
Similarity Score5%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score5%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaHodgkin Disease+1 more
Similarity Score5%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes
Similarity Score4%

Courtney DiNardo, MD

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesMyeloproliferative Neoplasm
Similarity Score4%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

Myelodysplastic SyndromesLeukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT05377827Phase 1PrincipalInvestigator

Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies

Acute Myeloid LeukemiaAdult T Cell LeukemiaAdult T Cell Lymphoma+12 more
Suspended
NCT02639559Phase 2PrincipalInvestigator

Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+7 more
Completed
NCT02416908Phase 1/2PrincipalInvestigator

Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia
Completed
NCT01027923Phase 1PrincipalInvestigator

IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute
Terminated
NCT01331590Early Phase 1PrincipalInvestigator

Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Completed

All 5 trials loaded